| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | SVP, Head Of Global Commercial
2 companies
Porter Derrell is a Director at Acumen Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $429K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Director | Sale+OE | 32,300 | $2.33 | $75,239.50 | -21.3% | - | - | |
| Feb 15, 2019 | ATRA Atara Biotherapeutics, Inc. | SVP, Head Of Global Commercial | Sale+OE | 5,909 | $40.00 | $236,360.00 | -21.4% | - | - | |
| May 15, 2018 | ATRA Atara Biotherapeutics, Inc. | SVP, Head Of Global Commercial | Sale+OE | 16,334 | $45.02 | $735,356.68 | -56.6% | - | - | |
| May 8, 2018 | ATRA Atara Biotherapeutics, Inc. | SVP, Head Of Global Commercial | Sell | 1,544 | $40.15 | $61,991.60 | -11.0% | - | - |